<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations/><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/D1774113-D5D2-4B7C-A412-66A90FE4B96F"><gtr:id>D1774113-D5D2-4B7C-A412-66A90FE4B96F</gtr:id><gtr:name>University of Cambridge</gtr:name><gtr:department>Biochemistry</gtr:department><gtr:address><gtr:line1>Lensfield Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:postCode>CB2 1EW</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/D1774113-D5D2-4B7C-A412-66A90FE4B96F"><gtr:id>D1774113-D5D2-4B7C-A412-66A90FE4B96F</gtr:id><gtr:name>University of Cambridge</gtr:name><gtr:address><gtr:line1>Lensfield Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:postCode>CB2 1EW</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/798CB33D-C79E-4578-83F2-72606407192C"><gtr:id>798CB33D-C79E-4578-83F2-72606407192C</gtr:id><gtr:name>EPSRC</gtr:name><gtr:address><gtr:line1>Polaris House</gtr:line1><gtr:line2>North Star Avenue</gtr:line2><gtr:line4>Swindon</gtr:line4><gtr:line5>Wiltshire</gtr:line5><gtr:postCode>SN2 1ET</gtr:postCode><gtr:region>South West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>CO_FUNDER</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/0284DA29-975E-4918-B2D3-2F81CDEC3394"><gtr:id>0284DA29-975E-4918-B2D3-2F81CDEC3394</gtr:id><gtr:firstName>Florian</gtr:firstName><gtr:surname>Hollfelder</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/1E2E96FA-1C32-4B2F-9B21-AB84D73DAF16"><gtr:id>1E2E96FA-1C32-4B2F-9B21-AB84D73DAF16</gtr:id><gtr:firstName>Laura</gtr:firstName><gtr:otherNames>Patricia</gtr:otherNames><gtr:surname>O'Neill</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/AAC7154D-A017-4D61-886B-BA5A9517E4FA"><gtr:id>AAC7154D-A017-4D61-886B-BA5A9517E4FA</gtr:id><gtr:firstName>Anthony</gtr:firstName><gtr:otherNames>John</gtr:otherNames><gtr:surname>Kirby</gtr:surname><gtr:roles><gtr:role><gtr:name>RESEARCHER_COI</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/B256FE45-3B91-4AD7-850D-3C6A70BAAF39"><gtr:id>B256FE45-3B91-4AD7-850D-3C6A70BAAF39</gtr:id><gtr:firstName>Karl</gtr:firstName><gtr:otherNames>Peter</gtr:otherNames><gtr:surname>Nightingale</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=BB%2FD014964%2F1"><gtr:id>F60A8834-FFA6-4E6F-911E-4ABBA5756CA3</gtr:id><gtr:title>Systematic Identification of Tunable Transfection Reagents for Stem Cell Biology</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>BB/D014964/1</gtr:grantReference><gtr:abstractText>Human embryonic stem (hES) cells are of great research interest, and offer the promise of therapeutic value, due to their pluripotency, or ability to develop into one of a large number of differentiated cell types. However, research on ES cells is currently hampered by the low transformation efficiencies observed by standard technologies based on non-viral lipid-mediated DNA delivery. Transformation is the ability to introduce DNA into cells, and permits the over-expression, 'knock-down' or biochemical 'tagging' of a specific protein, and is a standard means to assess the contribution of a given protein to the cell. We propose to overcome this technical barrier by establishing a systematic and results-informed search for new and effective reagents to chemically assist the transfection of stem cells. This will be performed by combining the expertise of two research groups, Cambridge (Florian Hollfelder) has broad experience of chemical synthesis, library development and high throughput screening, whereas Birmingham ( Karl Nightingale &amp;amp; Laura O'Neill) have research programmes centred on the use of primary and established leukaemic cell lines together with mouse and human ES cells. Specifically, we propose to generate a broad and chemically diverse library of modified polyethylene imines (PEIs), a reagent widely used in cell transfection, and establish a high throughput screen to identify effective and non-toxic reagents. Effective reagents will be subjected to structure/activity analysis to inform secondary library synthesis if necessary. This library will be screened against a number of tissue culture cell types of increasing technical difficulty. Initially we propose to use a leukaemic cell line called HL60 cells. This represents an ideal cell line for troubleshooting the screen as it grows quickly and easily, but is also a difficult cell type to transfect - this should be useful in establishing screen conditions for the stem cells. Importantly, any reagents identified will of immediate general interest as HL60 cells are widely used in research labs, being a good model of acute myeloid leukaemia. We then propose to utilise the experience gained from this initial phase to re-screen the library against several sorts of mouse ES cells, and finally against several sorts of human ES cells. An important part of the proposal at that the identified reagents will be subjected to a number of 'quality control' checks. This will primarily be at a functional level (or ensuring that the cells continue acting like stem cells), but we will also check that the reagents can perform the sorts of experiments that molecular biologists would want to use them for.</gtr:abstractText><gtr:technicalSummary>Human embryonic stem (hES) cells represent a significant research tool for dissecting developmental pathways, and offer great promise for therapeutic intervention. However, research on ES cells is currently hampered by the low transformation efficiencies observed by standard ('lipofectamine')-assisted technologies. Advances in this field are clearly required as this is an identified 'Scientific priority' for this initiative. We propose to overcome this technical barrier by generating a diverse library of polyethylene imines (PEIs), and Gemini surfactants, both classes of reagents with demonstrated transfection function. These libraries will be subjected to a systematic, reiterative screen by an established high throughput procedure based on GFP expression. Structure-activity relationship analysis will inform secondary library synthesis if required. We propose to use this procedure for screening a number of cell types of presumed increasing technical difficulty. Initially we propose to use a leukaemic cell line (HL60's). This represents an ideal 'troubleshooting' line since it grows in suspension, divides rapidly, and yet is noted for poor transformation efficiencies with current chemical reagents (lipofectamine). Importantly, any reagents identified will of immediate general interest as the line is widely used, being a good model of acute myeloid leukaemia. We then propose to utilise the experience gained from this initial phase to re-screen the library against a number of male and female mouse ES cell lines, and finally against several human ES cell lines. An important part of the proposal is that .identified reagents will be subjected to a number of 'quality control' checks. This will primarily be at a functional level, by ensuring that 'mock-transfected' cells (ie transfected without DNA) remain undifferentiated, but will progress down defined differentiation pathways given the appropriate cues.</gtr:technicalSummary><gtr:fund><gtr:end>2010-09-14</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/2512EF1C-401B-4222-9869-A770D4C5FAC7"><gtr:id>2512EF1C-401B-4222-9869-A770D4C5FAC7</gtr:id><gtr:name>BBSRC</gtr:name></gtr:funder><gtr:start>2006-09-15</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>382732</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs/><gtr:disseminationOutputs/><gtr:exploitationOutputs/><gtr:furtherFundingOutputs/><gtr:impactSummaryOutputs><gtr:impactSummaryOutput><gtr:description>The transfection reagents that were synthesised and systematically analysed in the period of this grant are now available for use by industrial scientists and the research community. Their transfection activity transcends existing commercial reagents (under their respective optimal conditions). The observed structure-activity relationships provide a basis for further improvements.</gtr:description><gtr:firstYearOfImpact>2011</gtr:firstYearOfImpact><gtr:id>39638B5F-2642-49EA-B7FC-6DD09A475A99</gtr:id><gtr:impactTypes><gtr:impactType>Economic</gtr:impactType></gtr:impactTypes><gtr:outcomeId>545bba18968385.06744606</gtr:outcomeId><gtr:sector>Chemicals,Healthcare</gtr:sector></gtr:impactSummaryOutput></gtr:impactSummaryOutputs><gtr:intellectualPropertyOutputs/><gtr:keyFindingsOutput><gtr:description>A new methodology for derivatising polyethylene imine has been shown to efficiently explore 'chemical space', i.e. provides a systematic way to identify and optimise transfection reagents. For example, trends can be identified that render a transfection reagent better or worse. This advance is significant, because thus far relating the composition of a transfection reagent with its function has been difficult. Our data suggest that this is possible to tune the efficiency of a transfection reagent as well as its cell-type selectivity. 

To transcend th elimits of PEI-mediated transfection, other scaffolds have been explored and were shown to be more efficient than PEI and its derivatives. For example, we have synthesised and tested peptide dendrimers that show interesting structure-activity relationships and transfection activity that transcends existing commercial reagents (under their respective optimal conditions).</gtr:description><gtr:exploitationPathways>So far four companies have expressed an interest in commercialisation and we are exploring commercialisation. The work started in this project has lead to new reagents for which patent protection is currently pursued.</gtr:exploitationPathways><gtr:id>A9478109-39E6-433B-B469-0C9C86A80A42</gtr:id><gtr:outcomeId>r-1243256676.237337877729766</gtr:outcomeId><gtr:sectors><gtr:sector>Retail</gtr:sector></gtr:sectors></gtr:keyFindingsOutput><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs><gtr:researchDatabaseAndModelOutput><gtr:description>We have tested a library of modified PEI in 96-well format for several cell lines and are pursuing collaborations with researchers in molecular biology on which we make these libraries available.</gtr:description><gtr:id>BD08D418-9BEF-4335-90E0-A6ED47AA105E</gtr:id><gtr:impact>The PEI library is tested in a transfection challenge in which splice-switching is attempted to cure Duchenne Muscular Dystrophy (DMD).</gtr:impact><gtr:outcomeId>r-9182774181.6479472b1f79ec</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>A library of PEI transfection reagents</gtr:title><gtr:type>Database/Collection of data</gtr:type><gtr:yearFirstProvided>2012</gtr:yearFirstProvided></gtr:researchDatabaseAndModelOutput></gtr:researchDatabaseAndModelOutputs><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>B3707519-FE64-4767-A29B-3C6AF6BCDA42</gtr:id><gtr:title>Functional Trade-Offs in Promiscuous Enzymes Cannot Be Explained by Intrinsic Mutational Robustness of the Native Activity.</gtr:title><gtr:parentPublicationTitle>PLoS genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a106514b6e1c9266e24f6ea3ca0ee972"><gtr:id>a106514b6e1c9266e24f6ea3ca0ee972</gtr:id><gtr:otherNames>Kaltenbach M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1553-7390</gtr:issn><gtr:outcomeId>585d3f86683b29.09421247</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>309D1A54-47B8-43DA-BF0E-65ADE91F7027</gtr:id><gtr:title>Relating chemical and biological diversity space: a tunable system for efficient gene transfection.</gtr:title><gtr:parentPublicationTitle>Chembiochem : a European journal of chemical biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d8b51ef4d669ed5f81df9fca1b2d4ae4"><gtr:id>d8b51ef4d669ed5f81df9fca1b2d4ae4</gtr:id><gtr:otherNames>Van Vliet LD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1439-4227</gtr:issn><gtr:outcomeId>m_8504982555136ad8d6</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DFF02F77-CF16-495E-9E19-8809CE2BECBE</gtr:id><gtr:title>Peptide Dendrimer-Lipid Conjugates as DNA and siRNA Transfection Reagents: Role of Charge Distribution Across Generations.</gtr:title><gtr:parentPublicationTitle>Chimia</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/88d75a1ad5837cf01d070da38eb35c66"><gtr:id>88d75a1ad5837cf01d070da38eb35c66</gtr:id><gtr:otherNames>Heitz M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0009-4293</gtr:issn><gtr:outcomeId>5a888d03deffa8.68644747</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7AB332A9-E0AB-4DFB-A93C-AFA4E8CE00FA</gtr:id><gtr:title>Ultrarapid generation of femtoliter microfluidic droplets for single-molecule-counting immunoassays.</gtr:title><gtr:parentPublicationTitle>ACS nano</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f6c0546667e78f6b491ad9ee752789c8"><gtr:id>f6c0546667e78f6b491ad9ee752789c8</gtr:id><gtr:otherNames>Shim JU</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1936-0851</gtr:issn><gtr:outcomeId>56db17ec844d59.76042737</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4EB31B92-DB23-4F08-980A-BC2C8D49FD3F</gtr:id><gtr:title>Fluid phase endocytosis contributes to transfection of DNA by PEI-25.</gtr:title><gtr:parentPublicationTitle>Molecular therapy : the journal of the American Society of Gene Therapy</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/102d864eff16481a3c9d6984a85df5a5"><gtr:id>102d864eff16481a3c9d6984a85df5a5</gtr:id><gtr:otherNames>Hufnagel H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1525-0016</gtr:issn><gtr:outcomeId>54628f4df3b9e8.74157663</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>386BA847-27BB-4D58-A52F-728EEE0BA88F</gtr:id><gtr:title>Peptide dendrimer/lipid hybrid systems are efficient DNA transfection reagents: structure--activity relationships highlight the role of charge distribution across dendrimer generations.</gtr:title><gtr:parentPublicationTitle>ACS nano</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/63e12cd99ade915b9d6bfa96cc3fd21e"><gtr:id>63e12cd99ade915b9d6bfa96cc3fd21e</gtr:id><gtr:otherNames>Kwok A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1936-0851</gtr:issn><gtr:outcomeId>54628eb57f4da2.94829279</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BD7A67B9-BF1D-43FA-ADA3-EDF565EE6E3A</gtr:id><gtr:title>Efficient Transfection of siRNA by Peptide Dendrimer-Lipid Conjugates.</gtr:title><gtr:parentPublicationTitle>Chembiochem : a European journal of chemical biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/63e12cd99ade915b9d6bfa96cc3fd21e"><gtr:id>63e12cd99ade915b9d6bfa96cc3fd21e</gtr:id><gtr:otherNames>Kwok A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1439-4227</gtr:issn><gtr:outcomeId>58bd3aad88c155.04422199</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">BB/D014964/1</gtr:identifier></gtr:identifiers><gtr:healthCategories/><gtr:researchActivities/><gtr:researchSubjects/><gtr:researchTopics><gtr:researchTopic><gtr:id>D05BC2E0-0345-4A3F-8C3F-775BC42A0819</gtr:id><gtr:text>Unclassified</gtr:text></gtr:researchTopic></gtr:researchTopics><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>